PepGen

PepGen is a pioneering biotechnology research company dedicated to developing a new generation of disease-modifying therapies. PepGen's mission is centered on creating innovative solutions for serious genetic neuromuscular and neurological disorders, driven by their proprietary Enhanced Delivery Oligonucleotide (EDO) platform. With a commitment to safely and effectively targeting the root cause of these conditions, PepGen is at the forefront of therapeutic advancements.

Located at 321 Harrison Ave, 8th Floor, Boston, Massachusetts 02118, US, PepGen is focused on transforming the landscape of treatment for genetic disorders. By leveraging cutting-edge bioscience, therapeutics, and biotechnology, PepGen aims to provide hope and improved outcomes for patients and families affected by these challenging diseases. The company’s expertise in life sciences, biology, and chemistry underpins its efforts to deliver better technology and superior therapeutic delivery methods.

PepGen is rapidly advancing its pipeline and expanding its capabilities to address unmet needs in the treatment of neuromuscular and neurological disorders. The company’s focus on innovation and patient-centric solutions positions PepGen as a key player in the biotechnology sector. We invite the manager of PepGen to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.